First-in-human study evaluating a novel long-acting injectable antiretroviral therapy provides promising early results on its ...

An Evangelical mission doctor has warned that millions of lives are at stake surrounding the potential dismantling of the U S ...

The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral ...

Kenyans living with HIV/AIDs have been told to take their antiretroviral (ARVs) pills daily without fear of running out. In a ...

People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

A groundbreaking HIV clinical trial in Africa has demonstrated that some women can control the virus without antiretroviral therapy for extended periods after receiving a combination of treatments, ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...